Targeted Therapies For Atopic Dermatitis: On the Cusp of a Golden Era
Credit(s): 1.00 (60 min)
Release Date: Feb 08, 2022
Expiration Date: Feb 08, 2023
MIPS Improvement Activity Under MACRA
Physicians – AMA PRA Category 1 Credit(s) ™
Physicians/ABIM MOC – ABIM MOC Point(s)
“Targeted Therapies For Atopic Dermatitis: On the Cusp of a Golden Era?” aims to provide allergists and dermatologists with up-to-date information on management of moderate to severe AD, including the health burden of uncontrolled disease, identification of patients with more severe disease who require treatment escalation, evidence-based use of newer targeted therapies, and how emerging therapies may impact AD management in the near term.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
Patient Resources Provided by
This program is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.